Kathrin Blagec
Kathrin Blagec
Research Associate, Medical University of Vienna
Verified email at meduniwien.ac.at
Title
Cited by
Cited by
Year
Incidence of exposure of patients in the United States to multiple drugs for which pharmacogenomic guidelines are available
M Samwald, H Xu, K Blagec, PE Empey, DC Malone, SM Ahmed, P Ryan, ...
PLoS One 11 (10), e0164972, 2016
292016
Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study
K Blagec, KM Romagnoli, RD Boyce, M Samwald
PeerJ 4, e1671, 2016
272016
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
K Blagec, R Koopmann, M Crommentuijn–van Rhenen, I Holsappel, ...
Journal of the American Medical Informatics Association 25 (7), 893-898, 2018
252018
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care
JA Miñarro-Giménez, K Blagec, RD Boyce, KP Adlassnig, M Samwald
PLoS One 9 (5), e93769, 2014
142014
Neural sentence embedding models for semantic similarity estimation in the biomedical domain
K Blagec, H Xu, A Agibetov, M Samwald
BMC bioinformatics 20 (1), 178, 2019
92019
Fast and scalable neural embedding models for biomedical sentence classification
A Agibetov, K Blagec, H Xu, M Samwald
BMC bioinformatics 19 (1), 541, 2018
92018
Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data
M Samwald, K Blagec, S Hofer, RR Freimuth
Pharmacogenomics 16 (15), 1713-1721, 2015
82015
Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
M Samwald, JA Minarro-Giménez, K Blagec, KP Adlassnig
eHealth, 25-31, 2014
72014
The Importance of Gene-Drug-Drug-Interactions in Pharmacogenomics Decision Support: An Analysis Based on Austrian Claims Data.
K Blagec, W Kuch, M Samwald
eHealth, 121-127, 2017
32017
Effects of Medical Device Regulations on the Development of Stand-Alone Medical Software: A Pilot Study.
K Blagec, D Jungwirth, D Haluza, M Samwald
eHealth, 180-187, 2018
12018
A critical analysis of metrics used for measuring progress in artificial intelligence
K Blagec, G Dorffner, M Moradi, M Samwald
arXiv preprint arXiv:2008.02577, 2020
2020
Multi-modal decision support to enable pharmacogenetics-based drug dosing across seven European countries: A24
K Blagec, R Koopmann, M Crommentuijn-van Rhenen, I Holsappel, ...
Clinical Chemistry and Laboratory Medicine 56 (6), 2018
2018
Making Pharmacogenomics Insights Available at the Point-of-Care
K Blagec, K Romagnoli, RD Boyce, S Hofer, M Samwald
PUBLIC HEALTH GENOMICS 19, 3-3, 2016
2016
An Ontology-Based
JA Minarro-Giménez, K Blagec, RD Boyce, KP Adlassnig, M Samwald
Mobile-Optimized System for Pharmacogenomic, 2014
2014
The Importance of Gene-Drug-Drug-Interactions in Pharmacogenomics Decision Support
K Blagec, W Kuch, M Samwald
The system can't perform the operation now. Try again later.
Articles 1–15